Neuroglee builds evidence-based, precision digital therapeutics for neurodegenerative diseases, which can augment disease management for improved patient outcomes.

MedRhythms is a digital therapeutics company that develops a medical device combining sensors, neuroscience, and music to help people with neurologic injury or disease to measure and improve walking.

Today, Neuroglee offers scalable and evidence-based programs for managing cognitive care within the home that leverages cutting-edge technology and continuous monitoring from a remote multidisciplinary clinical team.

Walking disability significantly decreases independence, reduces quality of life, increases falls, and adds to healthcare system burden. In the U.S. alone, over 100 million people have a walking disability caused by a neurologic injury or disease. But it doesn’t have to be this way. MedRhythms exists to rewrite this story by developing transformative and innovative therapeutics through the combination of advances in neuroscience and technology.